Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naji, Najib"'
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 671 (2024)
Background and Objectives: Dasatinib is one of the tyrosine kinase inhibitors. The main use of these agents is inhibition of cancerous cell proliferation. The therapeutic importance of tyrosine kinase inhibitors raises the necessity of many types of
Externí odkaz:
https://doaj.org/article/46de7a43b6ab4c888bd06636567c047a
Publikováno v:
European journal of drug metabolism and pharmacokinetics. 46(3)
Ibrutinib is an antineoplastic agent that reduces B-cell proliferation by inhibiting Bruton's tyrosine kinase. We describes population pharmacokinetics of ibrutinib in healthy adults, and explores potential patient characteristics associated with ibr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::182c418d0699cab167f76f65da696c6d
https://pubmed.ncbi.nlm.nih.gov/33740218
https://pubmed.ncbi.nlm.nih.gov/33740218
Autor:
Naji, Najib, Nasir, Idkaidek, M, Beshtawi, Mohammed, Bader, Isra', Admour, S Mahmood, Alam, Q, Zaman, Ruwayda, Dham
Publikováno v:
Biopharmaceuticsdrug disposition. 23(7)
A randomized, two-way, crossover study was conducted in 24 fasting, healthy, male volunteers to compare the bioavailability of two brands of metformin 500 mg tablets; Dialon (Julphar, UAE) as test and Glucophage (Lipha Pharmaceutical Industries, Fran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9bf61c393921c16f7f201388dfb4f87
https://pubmed.ncbi.nlm.nih.gov/12355581
https://pubmed.ncbi.nlm.nih.gov/12355581
Autor:
Naji, Najib, Nasir, Idkaidek, M, Beshtawi, Mohammed, Bader, Isra', Admour, S Mahmood, Alam, Q, Zaman, Ruwayda, Dham
Publikováno v:
Biopharmaceuticsdrug disposition. 23(5)
A randomized, two-way, crossover, bioequivalence study in 24 fasting, healthy, male volunteers was conducted to compare two brands of gliclazide 80 mg tablets, Glyzide (Julphar, UAE) as test and Diamicron (Servier Industries, France) as reference pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34d52f65d72ad024b3a46d583f1fd4d6
https://pubmed.ncbi.nlm.nih.gov/12116051
https://pubmed.ncbi.nlm.nih.gov/12116051
Publikováno v:
Accreditation & Quality Assurance; Aug2008, Vol. 13 Issue 8, p473-477, 5p
Autor:
Naji Najib, Nasir Idkaidek, M. Beshtawi, Mohammed Bader, Isra' Admour, S. Mahmood Alam, Q. Zaman, Ruwayda Dham
Publikováno v:
Biopharmaceutics & Drug Disposition; Sep2003, Vol. 24 Issue 6, p245, 5p